Oritavancin diphosphate
Kimyrsa is an intravenous antibiotic containing oritavancin diphosphate, a lipoglycopeptide used to treat certain bacterial infections like skin and soft tissue infections. It comes as a lyophilized powder that is mixed into a solution for injection. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Kimyrsa is an intravenous antibiotic containing oritavancin diphosphate, a lipoglycopeptide used to treat certain bacterial infections like skin and soft tissue infections. It comes as a lyophilized powder that is mixed into a solution for injection. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Oritavancin diphosphate", "mediaType": "text/html", "description": " Access the FDA dataset for Oritavancin diphosphate — ANDA 214155 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214155" } ] |
| identifier | ANDA214155 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "drug-manufacturers", "medications", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Oritavancin diphosphate |
